Can AI Accelerate Drug Repurposing for Faster Therapies?

Quantibody.ai helps unlock the full potential of drug repurposing by using AI algorithms to identify new uses for existing drugs. Our platform analyzes genomic data, disease signatures, and drug-target networks to match compounds with new therapeutic opportunities.

This approach significantly lowers development costs and regulatory risks by leveraging already-approved medications. We scan thousands of compounds to find hidden connections across disease pathways, patient phenotypes, and clinical outcomes.

By combining knowledge graphs, machine learning, and literature mining, we rapidly identify high-value repurposing candidates. Our system is ideal for rare diseases, emerging infections, and unmet clinical needs where traditional discovery is slow or infeasible.

Every recommendation includes supporting biological evidence and predicted mechanisms of action. We also assess market viability and patent landscape to ensure commercial relevance.

With Quantibody.ai, biotech and pharma companies can efficiently expand indications for their assets. Repurposing becomes a strategic tool—not just a shortcut—with our AI-powered approach.